/KGET

KGET Stock - CaliPharms, Inc.

Q: What is the analyst price target for KGET?

Analyst price target information is not currently available for KGET.

Q: What is KGET's market cap?

Market capitalization information is not currently available for KGET.

Basic Materials|Agricultural Inputs|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for KGET

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2013

FY2015

FY2016

FY2017

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-58.74

52W High$0.01

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2017	FY2016	FY2015	FY2013
Revenue	$12,000	N/A	N/A	N/A
Gross Profit	$12,000	N/A	N/A	N/A
Gross Margin	100.0%	N/A	N/A	N/A
Operating Income	$-1,346,720	$-357,860	$-340,280	$-184,184
Net Income	$-1,423,368	$-441,586	$-958,629	$-213,249
Net Margin	-11861.4%	N/A	N/A	N/A
EPS	$-0.00	$-0.00	$-0.00	$-0.00

Company Overview

CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry. The company was formerly known as Kleangas Energy Technologies, Inc. and changed its name to CaliPharms, Inc. in January, 2017. CaliPharms, Inc. is based in Temecula, California.

Visit Website

Frequently Asked Questions about KGET

What is KGET's current stock price?

CaliPharms, Inc. (KGET) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for KGET?

No analyst price targets are currently available for this stock.

What sector is CaliPharms, Inc. in?

CaliPharms, Inc. operates in the Basic Materials sector, specifically within the Agricultural Inputs industry. The company is traded on the OTC exchange.

What is KGET's market cap?

CaliPharms, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does KGET pay dividends?

No, CaliPharms, Inc. does not currently pay a dividend to shareholders.